Macrogen, Inc. (KOSDAQ:038290)

Market Cap	183.98B
Revenue (ttm)	179.98B
Net Income (ttm)	-700.38M
Shares Out	10.84M
EPS (ttm)	-65.98
PE Ratio	n/a
Forward PE	23.60
Dividend	300.00 (1.75%)
Ex-Dividend Date	Dec 29, 2025

Volume	27,487
Average Volume	48,054
Open	16,970
Previous Close	16,970
Day's Range	16,650 - 16,970
52-Week Range	14,720 - 19,460
Beta	0.68
RSI	50.68
Earnings Date	Feb 13, 2026

About Macrogen

Macrogen, Inc. provides precision medicine and bio-engineering healthcare services in Korea and internationally. It offers personal healthcare services, including disease prediction and wellness genetic, and DTC genetic testing services; MyPETGENE, a genetic testing service for companion animals; clinical services, such as precision medicine, genetic testing for cancer risk, NGS-based genetic panel lab, and GCLP services; and single cell expert services comprising single cell multi-omics and spatial transcriptome analysis, and single cell (In S...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1997
• Employees: 475
• Stock Exchange: KOSDAQ
• Ticker Symbol: 038290

Financial Performance

In 2024, Macrogen's revenue was 135.78 billion, an increase of 2.24% compared to the previous year's 132.80 billion. Losses were -7.60 billion, -54.78% less than in 2023.